Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Metabolic reprogramming driven by EZH2 inhibition depends on cell–matrix interactions

Journal of Biological Chemistry(2023)10.1016/j.jbc.2023.105485Source: DataRank Database

Metabolic reprogramming driven by EZH2 inhibition depends on cell–matrix interactions is a research paper published in Journal of Biological Chemistry (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)OA: goldTopics (32)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Jahid M. M. Islam ORCID,Richard M. Higashi ORCID,Penghui Lin ORCID,Christine F. Brainson ORCID,Andrew N. Lane ORCID

Live enrichment

PubMed:37992808 PMC:PMC10770523

University of Kentucky

Grant: 133123-RSG-19-081-01-TBG

University of Kentucky

Grant: 5P20GM121327

University of Kentucky

Grant: P30CA177558

University of Kentucky

Grant: R01CA237643

NIGMS NIH HHS

Grant: P20 GM121327

National Institutes of Health

Grant: 5R01CA237643-02

Targeting epigenetic heterogeneity to improve lung cancer immunotherapy response

National Institutes of Health

Grant: 1P20GM121327-01

University of Kentucky Center for Cancer and Metabolism

National Institutes of Health

Grant: 3P30CA177558-01S1

CTRP Supplement

American Cancer Society

National Institutes of Health

goldLicense: CC BY

publisherhttps://api.elsevier.com/content/article/PII:S0021925823025139?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0021925823025139?httpAccept=text/plain

Unpaywallhttp://www.jbc.org/article/S0021925823025139/pdf

Europe_PMChttps://europepmc.org/articles/PMC10770523

Europe_PMChttps://europepmc.org/articles/PMC10770523?pdf=render

MeSH Terms

Cell Line, TumorHumansPurine NucleotidesGene Expression Regulation, NeoplasticCitric Acid CycleGlycolysisPentose Phosphate PathwayGene Knockdown TechniquesPolycomb Repressive Complex 2Enhancer of Zeste Homolog 2 ProteinA549 CellsAdenocarcinoma of LungMetabolic Reprogramming

Keywords

Extracellular matrixSpheroidsEzh2Stable Isotope-resolved MetabolomicsGlucose/glutamine MetabolismMetabolic ReprogrammingCitric Acid CyclePolycomb Repressive Complex 2Adenocarcinoma of LungResearch Article Collection: MetabolismPentose Phosphate PathwayGene Expression Regulation, NeoplasticA549 CellsCell Line, TumorGene Knockdown TechniquesHumansEnhancer of Zeste Homolog 2 ProteinGlycolysisPurine Nucleotides